Effects of Qilantangzhining Capsule on Hepatocyte Apoptosis and Expression of Bax and Bcl-2 in Rats with Diabetes Mellitus and Hyperlipemia
- VernacularTitle:芪蓝糖脂宁胶囊对糖尿病合并高脂血症大鼠肝细胞凋亡及Bax、Bcl-2蛋白表达的影响
- Author:
Deqin ZHANG
;
Jianjun ZHANG
;
Gansheng ZHONG
- Publication Type:Journal Article
- From:
China Journal of Traditional Chinese Medicine and Pharmacy
2005;0(04):-
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To study the mechanism of Qilantangzhining Capsule in treating diabetes mellitus complicated with hyperlipemia. Method: Rats were fed with high sugar and fat food for 2 months, and then 2% streptozocin (STZ, 30mg/kg) was injected intraperitoneally to induce hyperglycemic and hyperlipemic model. Thereafter, the model rats were administrated the drug. Flow cytometry (FCM) were used to detect effects of the capsule on hepatocyte apoptosis and the expression of related regulating genes, Bax and Bcl-2. Result: The rate of cell apoptosis remarkably increased among the model rats, the expression of Bax was significantly enhanced and that of Bcl-2 was decreased. Qilantangzhining Capsule could remarkably decrease the rate of cell apoptosis, decrease the expression of Bax, and increase that of Bcl-2. Conclusion: Qilantangzhining Capsule can prevent hepatocyte apoptosis by adjust the expression of Bax and Bcl-2, and accordingly provide evidences for its role in adjusting the metabolic disorders of sugar and fat.
